Braidwell LP

Diversified strategySector-focusedMomentum follower

Total reported value

$3.0B

Reporting period: 2026-03-31 · Number of holdings: 88

BRAIDWELL LP disclosed 88 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $3.0B and a quarterly turnover rate of 53.2%.

Personality snowflake

Concentration: 7.51
Portfolio Stability: 53.17
Momentum/Contrarian: 100
Sector conviction: 100
Diversification: 100
Sizing Uniformity: 91.88

Recent moves

Trim GH 1.25 02-15-31
-41.9%　-$89.7M
Trim CAI
+2.5%　-$67.7M
Trim EWTX
-54.9%　-$55.4M
Add GLUE
+238.1%　$37.9M
Add ARGX
+173.9%　$36.0M
Add IRTC
+180.7%　$33.4M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	CAI	Caris Life Sciences INC	Stock-Other	4.78%	-1.96%	+2.47%
2	GH 1.25 02-15-31	Guardant Health INC	Stock-Healthcare	3.42%	-2.73%	-41.87%
3	RGEN 1 12-15-28	Repligen CORP	Stock-Healthcare	3.29%	-0.25%	—
4	NEO 0.25 01-15-28	Neogenomics INC	Stock-Healthcare	3.06%	—	—
5	NBIX	Neurocrine Biosciences INC	Stock-Healthcare	2.87%	-0.54%	-13.23%
6	GKOS	Glaukos CORP	Stock-Healthcare	2.74%	-0.59%	-17.19%
7	260	Centessa Pharmaceuticals-adr	Stock-Other	2.63%	+0.88%	-9.21%
8	XENE	Xenon Pharmaceuticals INC	Stock-Other	2.60%	—	-26.66%
9	DNTH	Dianthus Therapeutics INC	Stock-Other	2.52%	+0.84%	-29.40%
10	EWTX	Edgewise Therapeutics INC	Stock-Other	2.47%	-1.67%	-54.95%
11	IRTC	Irhythm Holdings INC	Stock-Healthcare	2.40%	+1.17%	+180.75%
12	NUVL	Nuvalent Inc-a	Stock-Other	2.39%	—	-14.73%
13	KOD	Kodiak Sciences INC	Stock-Other	2.31%	+0.46%	-12.26%
14	CGON	Cg Oncology INC	Stock-Other	2.22%	-0.26%	-47.35%
15	ATEC 0.75 03-15-30	Alphatec Holdings INC	Stock-Other	2.11%	+2.11%	NEW
16	ARGX	Argenx Se - Adr	Stock-Healthcare	2.07%	+1.24%	+173.93%
17	HNGE	Hinge Health Inc-a	Stock-Other	1.87%	—	+11.54%
18	ACAD	Acadia Pharmaceuticals INC	Stock-Healthcare	1.84%	—	+21.61%
19	GLUE	Monte Rosa Therapeutics INC	Stock-Other	1.76%	+1.28%	+238.13%
20	KRYS	Krystal Biotech INC	Stock-Healthcare	1.57%	—	-9.74%
21	SYRE	Spyre Therapeutics INC	Stock-Other	1.57%	—	-42.93%
22	GH	Guardant Health INC	Stock-Healthcare	1.54%	+1.54%	NEW
23	TMO	Thermo Fisher Scientific INC	Stock-Healthcare	1.52%	—	+15.10%
24	GENB	Generate Biomedicines INC	Stock-Other	1.50%	+1.50%	NEW
25	MBX	Mbx Biosciences INC	Stock-Other	1.49%	+0.46%	+46.52%
26	BTSG	Brightspring Health Services	Stock-Other	1.44%	—	-14.99%
27	CLDX	Celldex Therapeutics INC	Stock-Other	1.43%	—	-27.02%
28	NEO	Neogenomics INC	Stock-Healthcare	1.39%	-0.35%	+21.25%
29	APGE	Apogee Therapeutics INC	Stock-Other	1.34%	—	-16.76%
30	DRUG	Bright Minds Biosciences INC	Stock-Other	1.31%	+0.50%	+66.39%
31	CDNA	Caredx INC	Stock-Other	1.26%	—	+37.09%
32	ISRG	Intuitive Surgical INC	Stock-Healthcare	1.19%	-0.32%	-7.34%
33	INSP	Inspire Medical Systems INC	Stock-Healthcare	1.17%	-0.43%	+25.27%
34	PEN	Penumbra INC	Stock-Healthcare	1.15%	—	-4.36%
35	TMDX	Transmedics Group INC	Stock-Healthcare	1.09%	—	+4.46%
36	SLNOEUR	Soleno Therapeutics INC	Stock-Other	1.07%	-0.69%	-19.24%
37	DYN	Dyne Therapeutics INC	Stock-Other	1.02%	—	+13.78%
38	MRVI	Maravai Lifesciences Hldgs-a	Stock-Other	0.97%	—	+22.59%
39	ILMN	Illumina INC	Stock-Healthcare	0.94%	—	-15.00%
40	KYMR	Kymera Therapeutics INC	Stock-Other	0.94%	—	-25.69%
41	BMRN	Biomarin Pharmaceutical INC	Stock-Healthcare	0.94%	—	-17.37%
42	NRIX	Nurix Therapeutics INC	Stock-Other	0.91%	-0.41%	-19.83%
43	RYTM	Rhythm Pharmaceuticals INC	Stock-Other	0.90%	+0.90%	NEW
44	DHR	Danaher CORP	Stock-Healthcare	0.88%	—	+17.85%
45	✓	Establishment Labs Hldgs INC	Stock-Other	0.88%	+0.88%	NEW
46	TECX	Tectonic Therapeutic INC	Stock-Other	0.87%	—	-8.67%
47	NTRA	Natera INC	Stock-Healthcare	0.86%	—	+15.70%
48	CRVS	Corvus Pharmaceuticals INC	Stock-Other	0.86%	+0.86%	NEW
49	FULC	Fulcrum Therapeutics INC	Stock-Other	0.80%	—	+2.41%
50	✓	Zura Bio LTD	Stock-Other	0.79%	—	+25.42%

1–50 of 88

Portfolio Performance

Performance for Q3 2026

+18%

Performance Last 4 Quarters

+60.7%

Based on 69% of reported portfolio value with available pricing

Stdev: +25.3%
Beta: +0.48
Alpha: +25.2%
Max Drawdown: -8.5%
Annualized Perf: +32.6%
Batting Avg vs S&P: +50%
Sortino: +2.53
Stutzer: +0.37
Treynor: +0.66
Sterling: +2.68
Calmar: +3.82
Information Ratio: +0.72
Tracking Error: +25.5%
Stdev Down: +12.4%
Winning Months %: +71.4%
Losing Months %: +28.6%
Best 12 Months: +51.6%
Worst 12 Months: +18.4%
Efficiency Ratio: +0.5
Sharpe: +1.24
Stdev Sectors: 0%
Skewness: +0.04
Kurtosis: -0.52
Upside Potential: +3.98

Reported value over time

Sector allocation

Sector allocation over time

Quarterly history

Period	Holdings	Total value	Stability	Top holdings
2026-03-31	88	$3.0B	53	1CAI 2GH 1.25 02-15-31 3RGEN 1 12-15-28 Top holdings2026-03-31 1.CAI 2.GH 1.25 02-15-31 3.RGEN 1 12-15-28 4.NEO 0.25 01-15-28 5.NBIX 6.GKOS 7.260 8.XENE 9.DNTH 10.EWTX
2025-12-31	73	$3.1B	61	1CAI 2GH 1.25 02-15-31 3EWTX Top holdings2025-12-31 1.CAI 2.GH 1.25 02-15-31 3.EWTX 4.RGEN 1 12-15-28 5.NBIX 6.GKOS 7.NEO 0.25 01-15-28 8.NUVL 9.XENE 10.CGON
2025-09-30	73	$3.4B	63	1GH 1.25 02-15-31 2CAI 3NVCR 0 11-01-25 Top holdings2025-09-30 1.GH 1.25 02-15-31 2.CAI 3.NVCR 0 11-01-25 4.XENE 5.CGON 6.NBIX 7.RGEN 1 12-15-28 8.KRYS 9.NUVL 10.NEO 0.25 01-15-28
2025-06-30	55	$2.9B	0	1GH 1.25 02-15-31 2CAI 3NBIX Top holdings2025-06-30 1.GH 1.25 02-15-31 2.CAI 3.NBIX 4.NVCR 0 11-01-25 5.XENE 6.ARGX 7.RGEN 1 12-15-28 8.KRYS 9.ALGN 10.LEGN
2025-03-31	64	$2.8B	0	1GH 1.25 02-15-31 2NVCR 0 11-01-25 3NBIX Top holdings2025-03-31 1.GH 1.25 02-15-31 2.NVCR 0 11-01-25 3.NBIX 4.LEGN 5.RGEN 1 12-15-28 6.ARGX 7.XENE 8.IRTC 1.5 09-01-29 9.NEO 0.25 01-15-28 10.ALGN
2024-12-31	73	$3.4B	0	1GH 0 11-15-27 2BBIO 2.5 03-15-27 3NVCR 0 11-01-25 Top holdings2024-12-31 1.GH 0 11-15-27 2.BBIO 2.5 03-15-27 3.NVCR 0 11-01-25 4.NBIX 5.RGEN 1 12-15-28 6.XENE 7.GMED 0.375 03-15-25 8.NEO 0.25 01-15-28 9.LEGN 10.CGON
2024-09-30	81	$3.5B	0	1GH 0 11-15-27 2BBIO 2.5 03-15-27 3NVCR 0 11-01-25 Top holdings2024-09-30 1.GH 0 11-15-27 2.BBIO 2.5 03-15-27 3.NVCR 0 11-01-25 4.CGON 5.GMED 0.375 03-15-25 6.XENE 7.NBIX 8.NEO 0.25 01-15-28 9.APGE 10.APLSUSD
2024-06-30	75	$3.2B	0	1GH 0 11-15-27 2BBIO 2.5 03-15-27 3NVCR 0 11-01-25 Top holdings2024-06-30 1.GH 0 11-15-27 2.BBIO 2.5 03-15-27 3.NVCR 0 11-01-25 4.GMED 0.375 03-15-25 5.NBIX 6.CGON 7.XENE 8.APGE 9.NEO 0.25 01-15-28 10.IRWD 1.5 06-15-26
2024-03-31	70	$3.1B	0	1GH 0 11-15-27 2BBIO 2.5 03-15-27 3EXAS 0.375 03-01-28 Top holdings2024-03-31 1.GH 0 11-15-27 2.BBIO 2.5 03-15-27 3.EXAS 0.375 03-01-28 4.NVCR 0 11-01-25 5.APGE 6.GMED 0.375 03-15-25 7.NBIX 8.ARGX 9.PCVX 10.NEO 0.25 01-15-28
2023-12-31	72	$2.7B	0	1GH 0 11-15-27 2BBIO 2.5 03-15-27 3ASND 2.25 04-01-28 Top holdings2023-12-31 1.GH 0 11-15-27 2.BBIO 2.5 03-15-27 3.ASND 2.25 04-01-28 4.EXAS 0.375 03-01-28 5.NVCR 0 11-01-25 6.NBIX 7.PCVX 8.XENE 9.GMED 0.375 03-15-25 10.PODD 0.375 09-01-26
2023-09-30	86	$3.2B	0	1GH 0 11-15-27 2NVCR 0 11-01-25 3ASND 2.25 04-01-28 Top holdings2023-09-30 1.GH 0 11-15-27 2.NVCR 0 11-01-25 3.ASND 2.25 04-01-28 4.EXAS 0.375 03-01-28 5.NSTG 2.625 03-01-25 6.BBIO 2.5 03-15-27 7.NBIX 8.NVRO 2.75 04-01-25 9.PCVX 10.XENE
2023-06-30	82	$3.1B	0	1GH 0 11-15-27 2EXAS 0.375 03-01-28 3NVCR 0 11-01-25 Top holdings2023-06-30 1.GH 0 11-15-27 2.EXAS 0.375 03-01-28 3.NVCR 0 11-01-25 4.NSTG 2.625 03-01-25 5.ASND 2.25 04-01-28 6.BBIO 2.5 03-15-27 7.NVRO 2.75 04-01-25 8.NBIX 9.PCVX 10.ATEC 0.75 08-01-26
2023-03-31	81	$3.0B	0	1GH 0 11-15-27 2EXAS 0.375 03-01-28 3NSTG 2.625 03-01-25 Top holdings2023-03-31 1.GH 0 11-15-27 2.EXAS 0.375 03-01-28 3.NSTG 2.625 03-01-25 4.NVCR 0 11-01-25 5.ATEC 0.75 08-01-26 6.BBIO 2.5 03-15-27 7.NVRO 2.75 04-01-25 8.GKOS 9.OPHTEUR 10.NBIX
2022-12-31	90	$3.0B	0	1GH 0 11-15-27 2NSTG 2.625 03-01-25 3NVCR 0 11-01-25 Top holdings2022-12-31 1.GH 0 11-15-27 2.NSTG 2.625 03-01-25 3.NVCR 0 11-01-25 4.EXAS 0.375 03-01-28 5.ATEC 0.75 08-01-26 6.NVRO 2.75 04-01-25 7.GKOS 8.OPHTEUR 9.BIIB 10.PCVX

Holding changes this quarter

Braidwell LP's most significant position changes for 2026-03-31: Sold out: Irhythm Holdings INC (IRTC 1.5 09-01-29); New buy: Alphatec Holdings INC (ATEC 0.75 03-15-30); Sold out: Align Technology INC (ALGN); Sold out: Ironwood Pharmaceuticals (IRWD 1.5 06-15-26); New buy: Guardant Health INC (GH).

Position changes disclosed by Braidwell LP for the quarter ending 2026-03-31, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	GLUE	Monte Rosa Therapeutics INC	+1.3%	+238.13%	Add
2	ARGX	Argenx Se - Adr	+1.2%	+173.93%	Add
3	IRTC	Irhythm Holdings INC	+1.2%	+180.75%	Add
4	260	Centessa Pharmaceuticals-adr	+0.9%	-9.21%	Trim
5	DNTH	Dianthus Therapeutics INC	+0.8%	-29.40%	Trim
6	DRUG	Bright Minds Biosciences INC	+0.5%	+66.39%	Add
7	MBX	Mbx Biosciences INC	+0.5%	+46.52%	Add
8	KOD	Kodiak Sciences INC	+0.5%	-12.26%	Trim
9	RGEN 1 12-15-28	Repligen CORP	-0.3%	—	Unchanged
10	CGON	Cg Oncology INC	-0.3%	-47.35%	Trim
11	ISRG	Intuitive Surgical INC	-0.3%	-7.34%	Trim
12	✓	Engene Holdings INC	-0.3%	-21.54%	Trim
13	NEO	Neogenomics INC	-0.4%	+21.25%	Add
14	NRIX	Nurix Therapeutics INC	-0.4%	-19.83%	Trim
15	INSP	Inspire Medical Systems INC	-0.4%	+25.27%	Add
16	NBIX	Neurocrine Biosciences INC	-0.5%	-13.23%	Trim
17	VERA	Vera Therapeutics INC	-0.6%	-33.25%	Trim
18	GKOS	Glaukos CORP	-0.6%	-17.19%	Trim
19	SLNOEUR	Soleno Therapeutics INC	-0.7%	-19.24%	Trim
20	CVS	Cvs Health CORP	-0.7%	-48.48%	Trim
21	EWTX	Edgewise Therapeutics INC	-1.7%	-54.95%	Trim
22	CAI	Caris Life Sciences INC	-2%	+2.47%	Add
23	GH 1.25 02-15-31	Guardant Health INC	-2.7%	-41.87%	Trim
24	IRTC 1.5 09-01-29	Irhythm Holdings INC	—	EXIT	Sold out
25	ATEC 0.75 03-15-30	Alphatec Holdings INC	—	NEW	New buy
26	ALGN	Align Technology INC	—	EXIT	Sold out
27	IRWD 1.5 06-15-26	Ironwood Pharmaceuticals	—	EXIT	Sold out
28	GH	Guardant Health INC	—	NEW	New buy
29	GENB	Generate Biomedicines INC	—	NEW	New buy
30	RAPT	Rapt Therapeutics INC	—	EXIT	Sold out
31	LEGN	Legend Biotech Corp-adr	—	EXIT	Sold out
32	RYTM	Rhythm Pharmaceuticals INC	—	NEW	New buy
33	✓	Establishment Labs Hldgs INC	—	NEW	New buy
34	CRVS	Corvus Pharmaceuticals INC	—	NEW	New buy
35	ATEC	Alphatec Holdings INC	—	NEW	New buy
36	430	Terns Pharmaceuticals INC	—	EXIT	Sold out
37	DMRA	Damora Therapeutics INC	—	NEW	New buy
38	BSX	Boston Scientific CORP	—	NEW	New buy
39	BIOA	Bioage Labs INC	—	NEW	New buy
40	BIIB	Biogen INC	—	EXIT	Sold out
41	TARS	Tarsus Pharmaceuticals INC	—	NEW	New buy
42	ELV	Elevance Health INC	—	NEW	New buy
43	VTYXUSD	Ventyx Biosciences INC	—	EXIT	Sold out
44	NKTR	Nektar Therapeutics	—	NEW	New buy
45	ACHC	Acadia Healthcare Co INC	—	NEW	New buy
46	ORIC	Oric Pharmaceuticals INC	—	NEW	New buy
47	AVAH	Aveanna Healthcare Holdings	—	NEW	New buy
48	ZBIO 2.5 04-01-32	Zenas Biopharma INC	—	NEW	New buy
49	ICLR	ICON Public Limited Company	—	EXIT	Sold out
50	TGTX	Tg Therapeutics INC	—	NEW	New buy

FAQ

What is Braidwell LP and what type of investor is it?

Braidwell LP is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately $3.0B, spread across 88 disclosed positions.

What are Braidwell LP's largest equity positions?

Based on the latest 13F filing, Braidwell LP's top holdings by market value are: 1. Caris Life Sciences INC (CAI) — $143.2M (4.8%) 2. Guardant Health INC (GH 1.25 02-15-31) — $102.6M (3.4%) 3. Repligen CORP (RGEN 1 12-15-28) — $98.7M (3.3%) 4. Neogenomics INC (NEO 0.25 01-15-28) — $91.8M (3.1%) 5. Neurocrine Biosciences INC (NBIX) — $85.9M (2.9%)

What changes did Braidwell LP make in its most recent portfolio filing?

In the latest reported quarter, Braidwell LP made 49 notable position adjustments: 18 new positions were initiated, 8 existing holdings were added to, 14 positions were partially reduced, and 9 were completely exited. The largest of these moves: Sold out: Irhythm Holdings INC (IRTC 1.5 09-01-29); New buy: Alphatec Holdings INC (ATEC 0.75 03-15-30); Sold out: Align Technology INC (ALGN); Sold out: Ironwood Pharmaceuticals (IRWD 1.5 06-15-26); New buy: Guardant Health INC (GH)

What sectors does Braidwell LP focus on?

Braidwell LP is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 100.0%